Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

CUSIP: 03843E104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
120,192,308
Total 13F shares
23,788,793
Share change
+884,823
Total reported value
$48,053,747
Put/Call ratio
33%
Price per share
$2.02
Number of holders
57
Value change
+$1,931,780
Number of buys
31
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 03843E104?
CUSIP 03843E104 identifies AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2023

As of 31 Dec 2023, Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,788,793 shares. The largest 10 holders included Bratton Capital Management, L.P., ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, Vahanian & Associates Financial Planning Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and Bracebridge Capital, LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.